Works matching IS 11786981 AND DT 2025 AND VI 17

Results: 30

Health Economics Evaluation of Bictegravir/Emtricitabine/Tenofovir for a First-Line Treatment of HIV-1 Infection in China.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 393, doi. 10.2147/CEOR.S513601

By:

Wang, Wenjuan;
Zhou, Dachuang;
Zhou, Kejia;
Zhang, Di;
Li, Hao;
Zhang, Hongliu;
Jiang, Xin;
Wang, Ruihua;
Wang, Xi;
Tang, Wenxi

Publication type:

Article

Evaluating the Fiscal Impact of Antiretroviral Therapy for the Management of HIV in the United States 1987–2023.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 407, doi. 10.2147/CEOR.S520050

By:

Paquete, Ana Teresa;
Mordi, Uche;
Jarrett, James;
Thaliffdeen, Ryan;
Chaudhari, Paresh;
Connolly, Mark P;
Kotsopoulos, Nikos;
Sullivan, Patrick S

Publication type:

Article

Cost-Effectiveness of a Community First Responder System for Out-of-Hospital Cardiac Arrest in Poland.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 375, doi. 10.2147/CEOR.S510907

By:

Jaskuła, Jerzy;
Medic, Goran;
Verma, Sanjay;
Maurer, Joachim;
Kooy, Tom A;
de Greef, Bianca

Publication type:

Article

Budget Impact of Shifting the Treatment Setting of Unresectable Liver Metastases Associated with Primary Colorectal Cancer Using Y-90 Resin Microspheres from the Outpatient Hospital to the Office-Based Laboratory.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 387, doi. 10.2147/CEOR.S492369

By:

Sperling, David C;
Wallace, Katrine;
Oppen, Nanette von;
Weintraub, Joshua L

Publication type:

Article

The Impact of Obesity-Related Complications on Healthcare Costs – Outcomes of a Pharmacoeconomic Weight Loss Model.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 277, doi. 10.2147/CEOR.S500142

By:

Yilmaz, Esra Safak;
Malhan, Simten;
Gurser, Batu;
Yavuz, Dilek Gogas

Publication type:

Article

Comprehensive Insights into the Economic Burden of Rheumatoid Arthritis in Latin America: A Systematic Literature Review of Regional Perspectives.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 349, doi. 10.2147/CEOR.S498994

By:

Maldonado-Restrepo, Angela Isabel;
Acelas-Gonzalez, Gabriel E;
Rodríguez-Vargas, Gabriel-Santiago;
Rodriguez-Linares, Pedro;
Gonzalez-Rodriguez, Javier-Leonardo;
Rojas-Villarraga, Adriana;
Santos-Moreno, Pedro

Publication type:

Article

Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 289, doi. 10.2147/CEOR.S501404

By:

Shah, Bhavesh;
Sandin, Rickard;
Liu, Yun;
Bobolts, Laura R;
Hu, Yannan;
Mol, Isha;
Schepart, Alexander;
Hughes, David M;
Hart, Jim;
Hlavacek, Patrick

Publication type:

Article

Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 315, doi. 10.2147/CEOR.S501716

By:

Prosperini, Luca;
Pradelli, Lorenzo;
Santoni, Laura;
Perini, Daria;
Cottone, Salvatore;
Vercellino, Marco

Publication type:

Article

Clinical and Economic Burden of Managing Patients with Sickle Cell Disease Receiving Frequent Red Blood Cell Transfusions in the United States.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 303, doi. 10.2147/CEOR.S511996

By:

Udeze, Chuka;
Jerry, Michelle;
Evans, Kristin A;
Li, Nanxin;
Jain, Siddharth;
Andemariam, Biree

Publication type:

Article

A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 335, doi. 10.2147/CEOR.S509907

By:

Luminari, Stefano;
Pinto, Antonio;
Puccini, Benedetta;
D'Arpino, Alessandro;
Salè, Emanuela Omodeo;
Bellone, Marco;
Pradelli, Lorenzo;
Sabinot, Alice

Publication type:

Article

The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 233, doi. 10.2147/CEOR.S504462

By:

Nagi, Mouaddh Abdulmalik;
Almalki, Ziyad Saeed;
Thavorncharoensap, Montarat;
Sangroongruangsri, Sermsiri;
Turongkaravee, Saowalak;
Chaikledkaew, Usa;
Alqahtani, Abdulhadi M;
AlSharif, Lamis S;
Alsubaihi, Ibrahim A;
Alzarea, Abdulaziz I;
Alsultan, Mohammed M

Publication type:

Article

The Budget Impact of Cangrelor in the UK for the Treatment of Out-of-Hospital Cardiac Arrest Patients Who Require Percutaneous Coronary Intervention.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 189, doi. 10.2147/CEOR.S475503

By:

Modi, Bhavik;
Cain, Rob;
Stork, Richard;
Barwood, Caroline;
Tarpey, Gina;
Colucciello, Alessia

Publication type:

Article

Real World Evidence on Hormone Receptor Positive and Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer in Italy: Insights From 2017 to 2021 Data.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 147, doi. 10.2147/CEOR.S496606

By:

Perrone, Valentina;
Leogrande, Melania;
Cappuccilli, Maria;
Saragoni, Stefania;
Luciani, Andrea Cinti;
Esposti, Luca Degli

Publication type:

Article

Patient Experiences with the Impacts of Multiple Sclerosis & Disease-Modifying Therapies.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 199, doi. 10.2147/CEOR.S489929

By:

Talente, Bari;
Finseth, Lisbet T;
Blake, Natalie;
Costello, Kathleen;
Schmidt, Hollie;
Vandigo, Joe;
Oehrlein, Elisabeth M

Publication type:

Article

Healthcare Resource Utilization and Cost Comparison Between Palbociclib, Abemaciclib, and Ribociclib Among Patients with HR+/HER2− Metastatic Breast Cancer.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 247, doi. 10.2147/CEOR.S496100

By:

Pluard, Timothy J;
Sandin, Rickard;
Parikh, Rohan C;
Ward, Melea Anne;
Stansfield, Lindsay;
Nham, Tram;
Esterberg, Elizabeth;
Cha-Silva, Ashley S;
Shah, Bhavesh

Publication type:

Article

Economic Burden of Intravenous Decitabine Administration in Patients Affected by Acute Myeloid Leukemia Ineligible for Induction Chemotherapy and Impact of Oral Formulation Introduction: A Micro-Costing Study in Italy.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 171, doi. 10.2147/CEOR.S495401

By:

Costanzo, Alessandra Di;
Loreto, Luca;
Vassallo, Chiara;
Fiorentino, Francesca

Publication type:

Article

Dose Escalation Patterns and Associated Costs of Advanced Therapies for Ulcerative Colitis in France and the United Kingdom: A Retrospective Database Analysis.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 129, doi. 10.2147/CEOR.S481730

By:

Treuer, Tamás;
Richards, Melissa;
Mert, Can;
Dhesi, Endip;
Silva, Lidia;
Tan, Yubo;
Hoque, Sami

Publication type:

Article

Cost-Effectiveness of Oral Nutritional Supplements in Malnourished or at Risk of Disease-Related Malnutrition Cancer Patients in North Macedonia.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 265, doi. 10.2147/CEOR.S504094

By:

Nestorovska, Aleksandra Kapedanovska;
Sterjev, Zoran

Publication type:

Article

Cost-Effectiveness Analysis of Ofatumumab versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A 10-Year Markov Model.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 217, doi. 10.2147/CEOR.S503842

By:

Almalki, Ziyad Saeed;
Alshammari, Mashael Mafleh;
Almazrou, Saja H;
Alqahtani, Ohud Abd Alhadi;
Alkhayat, Maryam Riyadh;
Alnemari, Shahad Fahad;
Mukhemair, Haya Showky;
Alkredeas, Sara Mohamaad;
Alsuhibani, Abdulrahman A;
Asiri, Bushra Yousif;
Alalawi, Tala Nouraldin;
Alahmari, Abdullah K;
Alotaibi, Fahad Obaid

Publication type:

Article

Cost-Effectiveness Analysis for Managing Diabetic Foot Ulcer (DFU) in USA: Platelet-Rich Plasma (PRP) vs Standard of Care (SoC).

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 157, doi. 10.2147/CEOR.S496616

By:

Russo, Salvatore;
Landi, Stefano;
Simoni, Stefania

Publication type:

Article

Sensitivity of Cost-Effectiveness to Inclusion of Adverse Drug Events: A Scoping Review of Economic Models of Pharmacological Interventions for Diabetes, Diabetic Retinopathy, and Diabetic Macular Edema.

Published in:

2025

By:

Pesonen, Mari;
Kankaanpää, Eila

Publication type:

Literature Review

Real World Evaluation of Next-Day Molecular Respiratory Infectious Disease Testing on Healthcare Resource Utilization and Costs.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 79, doi. 10.2147/CEOR.S497838

By:

French, Andrea J;
Fragala, Maren S;
Evans, Azia S;
Upadhyay, Pallavi;
Goldberg, Steven E;
Reddy, Jairus

Publication type:

Article

Financial Cost of Treating Polytrauma in a Public Tertiary Hospital in the South-Eastern Democratic Republic of Congo: A Case Series Study.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 45, doi. 10.2147/CEOR.S496402

By:

Diyoka, Chadrack Kabeya;
Mwanvua, Laetitia Ngongo;
Kalemera, Marcellin Shauri;
Mukanga, Pascal Pambi;
Mjumbe, Criss Koba

Publication type:

Article

Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 55, doi. 10.2147/CEOR.S501532

By:

Furnback, Wesley;
Wu, Elizabeth;
Koh, Cloe Ying Chee;
Guzman, Jorge Fernando Nino de Rivera;
Kruhl, Christian;
Kotecha, Rupesh;
Wang, Bruce CM

Publication type:

Article

Cost-Benefit Analysis of Genetic Testing as a Prenatal Diagnostic Tool for Thalassemia: A Single-Center Study From Central Thailand.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 33, doi. 10.2147/CEOR.S500802

By:

Malasai, Kwandao;
Jittikoon, Jiraphun;
Udomsinprasert, Wanvisa;
Talungchit, Pattarawalai;
Youngkong, Sitaporn;
Sangroongruangsri, Sermsiri;
Mahasirimongkol, Surakameth;
Chaikledkaew, Usa

Publication type:

Article

Budget Impact and Cost–Benefit Analyses of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in Thailand.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 95, doi. 10.2147/CEOR.S504819

By:

Arunmanakul, Poukwan;
Phodha, Tuangrat;
Pinta-ay, Sakkarin;
Nimworapan, Mantiwee;
Phrommintikul, Arintaya;
Thammatacharee, Noppakun;
Dilokthornsakul, Piyameth

Publication type:

Article

Using QIP-MS to Guide the Timing of MRD Testing in Patients With Multiple Myeloma: A Budget Impact Analysis From the French Payer Perspective.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 107, doi. 10.2147/CEOR.S498848

By:

Siegfried, Christian;
Amarapala, Miyuru;
Leleu, Xavier;
Fusfeld, Lauren

Publication type:

Article

Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 69, doi. 10.2147/CEOR.S506043

By:

Liu, Jinan;
Desai, Karishma;
Teng, Chia-Chen;
Sturm, Daniel;
Stockbower, Grace;
Patadia, Hiten;
Willey, Vincent

Publication type:

Article

The Comparison of Cost-Effectiveness Between Magnetic Resonance Spectroscopy and Provocative Discography in the Identification of Chronic Low Back Pain Surgery Candidates.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 19, doi. 10.2147/CEOR.S501058

By:

Wilson, Leslie;
Beall, Douglas P;
Eastlack, Robert Kenneth;
Berven, Sigurd;
Lotz, Jeffrey C

Publication type:

Article

A Novel Model Using ML Techniques for Clinical Trial Design and Expedited Patient Onboarding Process.

Published in:

ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 1, doi. 10.2147/CEOR.S479603

By:

Iyer, Abhirvey;
Narayanaswami, Sundaravalli

Publication type:

Article